📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond. (2019)

First Author: Baillie GS

Attributed to: Priming Innovative Translational Research - the Glasgow Chemical Biology Programme funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41573-019-0033-4

PubMed Identifier: 31388135

Publication URI: http://europepmc.org/abstract/MED/31388135

Type: Journal Article/Review

Volume: 18

Parent Publication: Nature reviews. Drug discovery

Issue: 10

ISSN: 1474-1776